In-Office Treatment Options for Body Skin Laxity For patients experiencing more significant skin laxity following GLP-1-related weight loss, in-office options generally fall into a few categories
PC=Placebo An RCT of nondiabetic patients (N = 1961)1: After 68 weeks, mean weight loss was 15% (15 kg) versus 2% (3 kg) PC
The clinical effects appear to be influenced by several key factors, including patient characteristics (age, gender, ethnicity), concurrent medical conditions (particularly diabetes and obesity), and treatment parameters (drug type, dosage, duration) [9, 10]
BtaGSTA1-1, an alpha class GST identified in tight association with bovine steroidogenically active cells and shown to be hormonally regulated by gonadotropins in the bovine ovarian follicles, appeared to be a likely isomerase ( Based on mutational studies of human GSTs the five H-site residues in positions 10, 12, 111, 208, and 216 were judged to be of particular importance for the ketosteroid isomerase activity (Table 1)
The distinction matters and for many people dealing with gastrointestinal conditions, the correct answer is to use them together
